India Exchange Filings

Bharat Parenterals: USFDA Inspection Update

Bharat Parenterals Ltd says subsidiary Innoxel Lifesciences received a USFDA EIR for its Vadodara facility

  • USFDA closed its assessment following an unannounced pre-approval inspection conducted April 13–20, 2026.
  • The agency considered the facility ready to support commercial operations of the subject injectable product.
  • This is the facility’s second EIR.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.